mRNA |
GMX-1778 |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-09 |
mRNA |
piperlongumine |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
4e-09 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
4e-09 |
mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
5e-09 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
8e-09 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
9e-09 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
9e-09 |
mRNA |
tacedinaline |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-08 |
mRNA |
PDMP |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-08 |
mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-08 |